PRINOMIDE

Details

Stereochemistry	RACEMIC
Molecular Formula	C15H13N3O2
Molecular Weight	267.2826
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CN1C=CC=C1C(=O)C(C#N)C(=O)NC2=CC=CC=C2

InChI

InChIKey=KBQUAIAGRLAZGP-UHFFFAOYSA-N

InChI=1S/C15H13N3O2/c1-18-9-5-8-13(18)14(19)12(10-16)15(20)17-11-6-3-2-4-7-11/h2-9,12H,1H3,(H,17,20)

HIDE SMILES / InChI

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3266939 | https://www.ncbi.nlm.nih.gov/pubmed/8430060 | https://www.ncbi.nlm.nih.gov/pubmed/2903025 | https://www.ncbi.nlm.nih.gov/pubmed/2664168

Prinomide is a carbamoylpyrrolepropionitrile derivative patented by Ciba-Geigy A.-G. as a nonsteroidal anti-inflammatory drug that has disease-modifying activity in rheumatoid arthritis. In clinical trials, Prinomide demonstrate significant improvement in symptom score and laboratory variables.

Originator

Approval Year

PubMed

Title	Date	PubMed
Effect of a new antirheumatic drug (CGS10787B) on antibody formation and delayed-type hypersensitivity in BALB/c mice.	1988	3266939

Patents

Sample Use Guides

In Vivo Use Guide

250, 500, and 1000 mg every 12 hr for 28 days to healthy male volunteers.

Route of Administration: Oral

Name

Type

Language

PRINOMIDE

Official Name

English

Prinomide [WHO-DD]

Common Name

English

prinomide [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C257